|
🐜
|
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
10 auth.
R. Cantón,
N. Cobos,
J. Gracia,
F. Baquero,
J. Honorato,
S. Gartner,
...
A. Álvarez,
A. Salcedo,
A. Oliver,
E. García-Quetglas
|
7 |
2005 |
7
🐜
|
|
🐜
|
Development and validation of a questionnaire to assess asthma control in pediatrics
7 auth.
E. Pérez-Yarza,
X. Badia,
C. Badiola,
N. Cobos,
J. Garde,
M. Íbero,
...
J. Villa
|
5 |
2009 |
5
🐜
|
|
🐜
|
[Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire].
10 auth.
M. Perpiñá Tordera,
J. Viejo,
J. Sanchís,
X. Badia,
N. Cobos,
C. Picado,
...
V. Sobradillo,
J. Martínez González del Río,
F. Duce,
L. Muñoz Cabrera
|
5 |
2008 |
5
🐜
|
|
🐢
|
Parents' adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system.
K. Nikander,
L. Arheden,
J. Denyer,
N. Cobos
|
5 |
2003 |
5
🐢
|
|
🐬
|
Enhanced oxidative damage in cystic fibrosis patients
C. Domínguez,
S. Gartner,
S. Linan,
N. Cobos,
A. Moreno
|
5 |
1998 |
5
🐬
|
|
🦁
|
DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres
7 auth.
N. Cobos,
I. Danés,
S. Gartner,
M. González,
S. Linan,
J. Arnau,
...
on behalf of the Bild Study group
|
4 |
2000 |
4
🦁
|
|
🐜
|
Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences
13 auth.
X. Estivill,
R. Llevadot,
J. Giménez,
V. Nunes,
T. Casals,
L. Ortigosa,
J. Pérez-Frías,
J. Dapena,
J. Ferrer,
J. Pena,
...
L. Pena,
N. Cobos,
C. Vázquez
|
4 |
1995 |
4
🐜
|
|
🐜
|
Lung transplantation in young infants with interstitial pneumonia.
12 auth.
A. Moreno,
J. Maestre,
J. Balcells,
C. Marhuenda,
N. Cobos,
A. Roman,
...
J. Soler,
N. Montferrer,
S. Linan,
S. Gartner,
J. Roqueta,
J. Majó
|
4 |
2003 |
4
🐜
|
